Mission Wealth Management, LP Catalyst Pharmaceuticals, Inc. Transaction History
Mission Wealth Management, LP
- $4.24 Billion
- Q4 2024
A detailed history of Mission Wealth Management, LP transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Mission Wealth Management, LP holds 10,100 shares of CPRX stock, worth $229,270. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,100Holding current value
$229,270% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CPRX
# of Institutions
342Shares Held
98.6MCall Options Held
19.1KPut Options Held
51.1K-
Black Rock Inc. New York, NY18.7MShares$424 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$191 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY6.23MShares$141 Million2.3% of portfolio
-
State Street Corp Boston, MA5.69MShares$129 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$68.5 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.33B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...